HIGHLIGHTS
- who: Loes H. Willems from the Osaka University, Japan have published the research: Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trial, in the Journal: (JOURNAL)
- what: The authors investigated the potential impact of switching ASA monotherapy to DPI, by combining ASA with low-dose rivaroxaban, on macro- and microvascular endothelial dysfunction in patients with PAD and observed no differences.
- how: The study was conducted in accordance with the latest revision of the Declaration of Helsinki and Good Clinical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.